# Skåne University Hospital / Lund University Cancer Centre

Source: https://onco.cc/institutions/lund-skane/  
OnCo record `lund-skane` (Institution). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Southern Sweden's university hospital and Lund University's cancer centre, known for the population-wide SCAN-B breast cancer sequencing project.

## Summary

Skåne University Hospital in Lund and Malmö is the tertiary cancer centre for southern Sweden, and Lund University Cancer Centre coordinates research across its Medicon Village campus. Åke Borg and Lao Saal established the Sweden Cancerome Analysis Network-Breast (SCAN-B), which has sequenced the transcriptomes of breast cancers from consecutive patients across the region since 2010 and reports gene expression subtypes back into care, and Lund groups are strong in melanoma and prostate genomics, paediatric oncology and radiation physics linked to the MAX IV synchrotron. Lund also spun out antibody company BioInvent and hosts a Swedish node for CAR-T and haematological trials.

## Fields

- Kind: Institution
- Last checked: 2026-09-09
- Also known as: SUS; LUCC; Lund University Cancer Centre
- City: Lund, SE
- Type: hospital
- Website: https://www.skane.se/en/skane-university-hospital

## Sources

- Skåne University Hospital: https://www.skane.se/en/skane-university-hospital
- Lund University Cancer Centre: https://www.lucc.lu.se
- SCAN-B: https://www.scan-b.lu.se

## Connected records

- cancers: [HR-positive / HER2-negative breast cancer](https://onco.cc/cancers/breast-hr-positive/), [Melanoma](https://onco.cc/cancers/melanoma/), [Prostate cancer](https://onco.cc/cancers/prostate/), [Triple-negative breast cancer (TNBC)](https://onco.cc/cancers/tnbc/)
- fronts: [Diagnostics & Biomarkers](https://onco.cc/fronts/diagnostics/)
- technologies: [Germline (hereditary) testing](https://onco.cc/technologies/germline-testing/), [Monoclonal antibodies](https://onco.cc/technologies/monoclonal-antibody/), [RNA sequencing & expression profiling](https://onco.cc/technologies/rna-seq/), [Whole-exome & whole-genome sequencing](https://onco.cc/technologies/wes-wgs/)
- institutions: [Karolinska University Hospital](https://onco.cc/institutions/karolinska/), [Sahlgrenska University Hospital / Sahlgrenska Center for Cancer Research](https://onco.cc/institutions/sahlgrenska/)
- terms: [PAM50 / intrinsic subtypes](https://onco.cc/terms/pam50/)
- people: [Carolina Samuelsson](https://onco.cc/people/carolina-samuelsson/), [Kristina Lång](https://onco.cc/people/kristina-lang/), [Pamela Buchwald](https://onco.cc/people/pamela-buchwald/)
- key papers: [Comparison of SP142 and 22C3 PD-L1 assays in a population-based cohort of triple-negative breast cancer patients in the context of their clinically established scoring algorithms](https://onco.cc/key-papers/paper-sigurjonsdottir-sp142-22c3-tnbc-bcr-2023/), [Whole-genome sequencing of triple-negative breast cancers in a population-based clinical study](https://onco.cc/key-papers/paper-staaf-tnbc-whole-genome-scan-b-nat-med-2019/)
- companies: [Scandinavian Sarcoma Group](https://onco.cc/companies/scandinavian-sarcoma-group/)

---
JSON: https://onco.cc/api/v1/entities/lund-skane.json